Symptoms, Stages & Treatment Guide

Congestive heart failure (CHF) in canines is a progressive condition in which the heart can no longer pump blood efficiently enough to meet the body's needs, causing fluid to accumulate in the lungs (pulmonary edema), abdomen (ascites), or chest cavity (pleural effusion). It is not a single disease but rather the end-stage result of several underlying cardiac disorders — most commonly degenerative mitral valve disease (DMVD) and dilated cardiomyopathy (DCM). According to the Merck Veterinary Manual, CHF affects an estimated 10% of dogs seen in primary care veterinary practices, with prevalence rising sharply in senior animals. Small-breed dogs over age eight and large-breed dogs with genetic predispositions are disproportionately affected. While CHF itself cannot be cured, modern veterinary cardiology offers treatment protocols that can extend quality life by months to years when the disease is caught early.

What Causes Congestive Heart Failure in Dogs?

CHF develops when the heart's pumping ability deteriorates to the point where blood backs up into the circulatory system, increasing pressure in the veins and forcing fluid into surrounding tissues. The two most common underlying causes account for the vast majority of cases:

Degenerative Mitral Valve Disease (DMVD): This condition — sometimes called endocardiosis — involves the thickening and distortion of the mitral valve on the left side of the heart. It accounts for approximately 75% of all canine heart disease. DMVD is overwhelmingly seen in small and medium breeds: Cavalier King Charles Spaniels, Miniature Poodles, Dachshunds, and Chihuahuas. The valve gradually leaks, forcing the left atrium to enlarge, and over months or years the heart compensates until it can no longer keep up.

Dilated Cardiomyopathy (DCM): In DCM, the heart muscle itself weakens and the chambers dilate, reducing contractile force. This condition predominates in large and giant breeds — Doberman Pinschers, Great Danes, Irish Wolfhounds, and Boxers. The FDA has also investigated potential links between certain grain-free diets containing peas, lentils, and potatoes and DCM in breeds not typically predisposed, though the exact causal mechanism remains under study as of 2026.

Less common causes include congenital heart defects (patent ductus arteriosus, subaortic stenosis), heartworm disease (Dirofilaria immitis infection), myocarditis (inflammation of the heart muscle), and pericardial effusion (fluid around the heart compressing it).

Recognizing the Symptoms: Early Warnings vs. Advanced Signs

One of the biggest challenges with CHF is that early-stage heart disease — classified by the ACVIM (American College of Veterinary Internal Medicine) as Stage B1 or B2 — often produces no visible symptoms at all. The heart compensates remarkably well until it simply can't anymore. That's why understanding the progression of signs is critical.

Symptom Checklist by Disease Stage

Stage	Symptoms	What's Happening Internally
Stage B1 (Asymptomatic)	No visible signs; heart murmur detected on routine exam	Valve disease or muscle changes present but heart compensating fully
Stage B2 (Asymptomatic but Progressive)	Heart murmur louder (grade 3+); possible mild exercise intolerance; heart enlargement on X-ray	Heart enlarging, compensation mechanisms activated (RAAS system), but no fluid buildup yet
Stage C (Clinical CHF — First Episode)	Persistent cough (especially at night or when lying down), rapid breathing at rest (>30 breaths/min sleeping), exercise intolerance, reduced appetite, mild weight loss	Fluid accumulating in lungs (left-sided) or abdomen (right-sided); body's compensatory mechanisms overwhelmed
Stage D (Refractory/End-Stage)	Severe labored breathing, fainting episodes (syncope), pronounced abdominal swelling, extreme lethargy, cold extremities, bluish gums, cachexia (muscle wasting)	Standard medications no longer controlling fluid buildup; organ perfusion failing; multiple systems affected

A practical monitoring tip: Count your dog's resting respiratory rate (RRR) while they sleep. Place your hand gently on their ribcage and count each rise-and-fall as one breath. Time 15 seconds and multiply by four. A normal sleeping RRR is under 25 breaths per minute. If it consistently exceeds 30, contact your veterinarian — this is one of the earliest at-home indicators of fluid buildup and is recommended by veterinary cardiologists as a daily monitoring tool.

Breed Predisposition and Risk Factors

The Cavalier King Charles Spaniel deserves special mention: this breed has such a high genetic predisposition to mitral valve disease that the AKC recommends cardiac screening annually starting at age one. Responsible breeders should provide OFA (Orthopedic Foundation for Animals) cardiac clearance certificates for both parents.

How Veterinarians Diagnose CHF: Tests, Timelines, and Costs

Diagnosing CHF is a multi-step process. Your veterinarian will build a clinical picture from several data points — no single test confirms CHF in isolation.

Total initial diagnostic cost: Expect $800–$2,200 for a comprehensive cardiac workup, depending on whether a specialist performs the echocardiogram and your geographic region. Metropolitan areas and coastal cities trend toward the higher end.

Treatment Options: Medications, Procedures, and Ongoing Management

CHF treatment in dogs is not curative — it is management-focused, aimed at reducing fluid buildup, improving heart function, and maintaining quality of life. The standard protocol typically involves a combination of medications, often called the "CHF cocktail."

Common CHF Medications — Comparison Table

Medication	Drug Class	Purpose	Typical Dose Range	Monthly Cost (30 lb dog)	Key Side Effects
Furosemide (Salix®)	Loop diuretic	Removes excess fluid from lungs/abdomen	1–4 mg/kg every 8–12 hrs	$10–$25	Dehydration, increased thirst/urination, electrolyte imbalance
Pimobendan (Vetmedin®)	Inodilator (positive inotrope + vasodilator)	Strengthens heart contractions, dilates blood vessels	0.25–0.3 mg/kg every 12 hrs	$45–$90	Mild GI upset, lethargy (rare); must be given on empty stomach
Enalapril (Enacard®) or Benazepril	ACE inhibitor	Reduces blood pressure, decreases cardiac afterload	0.5 mg/kg every 12–24 hrs	$15–$35	Kidney strain (requires monitoring), low blood pressure
Spironolactone	Potassium-sparing diuretic / aldosterone antagonist	Reduces fibrosis, mild diuretic effect	1–2 mg/kg every 12 hrs	$15–$30	Facial dermatitis (rare, mostly in Cavaliers)
Sildenafil (Viagra® — compounded)	Pulmonary vasodilator	Treats pulmonary hypertension secondary to left-sided CHF	1–3 mg/kg every 8–12 hrs	$30–$75	Low blood pressure, GI upset
Digoxin	Cardiac glycoside	Slows heart rate, mild positive inotrope	0.003–0.005 mg/kg every 12 hrs	$15–$30	Narrow therapeutic window — toxicity risk; requires blood level monitoring

Pimobendan deserves particular attention. The landmark EPIC study (Evaluating Pimobendan In Cardiomyopathy) and the subsequent VETSCOPE and EPIC trials demonstrated that starting pimobendan in Stage B2 DMVD dogs (those with heart enlargement but not yet in failure) delayed the onset of CHF by a median of approximately 15 months. This was a significant finding that shifted veterinary cardiology toward earlier intervention. Your veterinarian will determine if your dog qualifies based on echocardiographic measurements.

Surgical and Interventional Options

For certain congenital defects causing CHF — such as patent ductus arteriosus (PDA) — minimally invasive catheter-based occlusion procedures can be curative. These are performed at veterinary teaching hospitals and specialty centers and cost $3,500–$7,000. For acquired valve disease, surgical mitral valve repair has been performed at a small number of specialized centers (notably in Japan and France), but it is not widely available in the United States and costs $15,000–$25,000+ including cardiopulmonary bypass.

For heartworm-induced CHF, the treatment protocol is entirely different: adulticide therapy with melarsomine (Immiticide®) administered in a staged protocol over 2–3 months, combined with strict exercise restriction. Consult your veterinarian for this specific pathway.

Prognosis and Life Expectancy by Stage

Prognosis varies enormously depending on the underlying cause, the stage at diagnosis, and how well the dog responds to medication. The following table reflects typical outcomes reported in veterinary cardiology literature — individual dogs may do better or worse.

Prognosis by CHF Stage

Stage at Diagnosis	Median Survival Time	Quality of Life Notes
Stage B2 (pre-failure, on pimobendan)	Median ~26–34 months before CHF onset; many live 3+ years total	Normal activity; medication slows progression
Stage C (first CHF episode, stabilized)	Median 6–12 months after first episode (DMVD); 3–9 months (DCM)	Good days and bad days; medication adjustments frequent
Stage D (refractory)	Weeks to 3–4 months typically	Escalating medication doses; hospitalizations; quality of life assessment critical

It's important to understand that these are medians — meaning half of dogs do better, half do worse. Some dogs with well-managed DMVD live 18–24 months in Stage C with good quality of life, while DCM in Dobermans tends to progress more rapidly due to the aggressive nature of the disease in that breed. Always consult your veterinarian for a prognosis specific to your dog's individual case.

Home Care and Daily Management

Once your dog is stabilized on medications, the day-to-day management you provide at home becomes one of the most important factors in their ongoing quality of life.

Daily Monitoring Routine

• Resting respiratory rate (RRR): Count breaths while sleeping, same time each day. Record in a log. Alert your vet if it trends upward over 2–3 days or exceeds 30 breaths/minute.
• Weight: Weigh weekly on the same scale. Sudden weight gain of 2+ lbs in 48 hours often means fluid retention — call your vet.
• Appetite and energy level: Note any decline. Cardiac cachexia (muscle wasting despite adequate calories) is common in advanced CHF.
• Coughing frequency: Track whether coughing increases at night, after exercise, or when lying down.

Nutritional Adjustments

Sodium restriction is a cornerstone of CHF management. Most commercial dog foods contain 0.3–0.5% sodium on a dry-matter basis, which is too high for a cardiac patient. Your veterinarian may recommend a prescription cardiac diet such as:

• Hill's Prescription Diet h/d® (Heart Care) — Sodium-restricted (0.08–0.12% DM), supplemented with L-carnitine, taurine, and fish oil. Cost: approximately $85–$110 for a 27.5 lb bag.
• Royal Canin Veterinary Diet Cardiac® — Moderate sodium restriction with adapted protein levels. Cost: approximately $80–$100 for a 22 lb bag.
• Purina Pro Plan Veterinary Diets NF Kidney Function® — Sometimes used off-label for cardiac patients due to low sodium and phosphorus. Cost: approximately $70–$90 for a 20 lb bag.

Supplementation with omega-3 fatty acids (EPA and DHA) at doses of 30–40 mg combined EPA+DHA per kg of body weight daily has shown benefit in reducing cardiac cachexia and inflammation, per research published in the Journal of Veterinary Internal Medicine. Fish oil capsules or veterinary-specific products like Nordic Naturals Omega-3 Pet are common choices. Always confirm dosing with your veterinarian.

Exercise and Lifestyle

Dogs with CHF should have controlled, gentle exercise — short leash walks of 10–15 minutes on flat terrain, avoiding heat, humidity, and exertion that causes panting or coughing. Avoid stressful situations, and keep the home environment cool (under 75°F / 24°C). For dogs in Stage C or D, a harness is preferable to a collar, which can compress the trachea and trigger coughing.

Understanding the Costs: Initial, Ongoing, and Emergency

CHF is a financially significant condition. Planning for costs helps avoid crisis decisions.

Estimated CHF Treatment Costs

Expense Category	Low Estimate	High Estimate	Frequency
Initial diagnostic workup (exam, X-rays, echo, bloodwork)	$800	$2,200	One-time
Monthly medications (typical 30 lb dog, 2–3 drugs)	$60	$200	Monthly
Prescription cardiac diet	$70	$110	Monthly (varies by dog size)
Recheck exams with bloodwork (kidney/electrolyte monitoring)	$150	$350	Every 3–6 months
Emergency decompensation hospitalization	$1,500	$5,000+	As needed (oxygen therapy, IV diuretics, monitoring)
Specialist cardiology consultation	$200	$450	Initial + annual rechecks
Estimated first-year total	$3,500	$8,000+	—

Pet insurance can offset some costs, but most policies exclude pre-existing conditions. If your dog is young and healthy now, enrolling before any cardiac diagnosis is the most financially strategic move. Companies like Trupanion, Healthy Paws, and Nationwide offer policies with chronic condition coverage — review the cardiac exclusion clauses carefully.

Prevention Strategies

Not all CHF is preventable — genetic valve disease and cardiomyopathy cannot be entirely avoided — but several measures reduce risk or delay onset:

• Heartworm prevention: Year-round heartworm preventive (ivermectin-based products like Heartgard Plus®, milbemycin-based like Interceptor Plus®, or topical Revolution Plus®) eliminates heartworm-induced CHF entirely when compliance is maintained. Cost: $6–$15/month.
• Weight management: Maintaining a body condition score (BCS) of 4–5 out of 9 reduces cardiac workload. Every pound of excess weight forces the heart to pump blood through additional tissue.
• Dental care: Advanced periodontal disease allows oral bacteria to enter the bloodstream, potentially seeding heart valve infections (endocarditis). Daily tooth brushing and professional cleanings under anesthesia when recommended by your vet reduce this risk.
• Breed-appropriate cardiac screening: For Cavaliers, annual auscultation starting at age 1 and echocardiograms from age 5. For Dobermans, annual Holter monitoring (24-hour ECG) and echocardiograms starting at age 2–3. Early detection at Stage B2 allows pimobendan to delay CHF onset.
• Diet review: Discuss your dog's diet with your veterinarian, particularly if feeding a grain-free or boutique diet. The FDA's ongoing investigation into diet-associated DCM suggests choosing diets from manufacturers that employ full-time veterinary nutritionists and conduct AAFCO feeding trials.

Frequently Asked Questions

This article is intended for informational purposes and does not replace professional veterinary advice. If you suspect your dog is showing signs of congestive heart failure, consult your veterinarian promptly for diagnosis and a tailored treatment plan. For suspected poisoning or medication reactions, contact ASPCA Animal Poison Control at (888) 426-4435 (24/7, consultation fee applies).